Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Double-blind, Randomised, Placebo Controlled, Proof-of-concept Study in Subjects With Abdominal or Thoracic Chronic Scar Pain to Assess the Analgesic Properties of Intradermal Doses of Dysport

Trial Profile

A Double-blind, Randomised, Placebo Controlled, Proof-of-concept Study in Subjects With Abdominal or Thoracic Chronic Scar Pain to Assess the Analgesic Properties of Intradermal Doses of Dysport

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Dec 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary) ; Lidocaine
  • Indications Scars
  • Focus Proof of concept; Therapeutic Use
  • Acronyms RESPITE
  • Sponsors Ipsen
  • Most Recent Events

    • 29 Nov 2018 Status changed from not yet recruiting to recruiting.
    • 28 Sep 2018 Planned initiation date changed from 10 Sep 2018 to 8 Oct 2018.
    • 18 Sep 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top